Colin Basham

Dr. Colin Basham received his PhD in Biomedical Engineering from the University of Tennessee, Knoxville, in spring 2023. His research there focused on how the material properties of inorganic nanoparticles impact their interactions with model cell membranes, which can dictate passive membrane translocation and nanoparticle-induced cellular toxicity. Dr. Basham joined the CCNTP in fall 2023 under the guidance of Dr. Alexander Kabanov, Dr. Charles Perou and Dr. Benjamin Vincent. His current work focuses on the development of lipid nanoparticles to deliver mRNAs for targeted cancer treatment.